These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15265562)
1. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562 [TBL] [Abstract][Full Text] [Related]
2. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats]. Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034 [TBL] [Abstract][Full Text] [Related]
3. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874 [TBL] [Abstract][Full Text] [Related]
4. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats. Yang ZQ; Xu J; Pan P; Zhang XN Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227 [TBL] [Abstract][Full Text] [Related]
5. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats]. Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107 [TBL] [Abstract][Full Text] [Related]
6. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid. Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721 [TBL] [Abstract][Full Text] [Related]
7. Absorption mechanism of cyclosporine A loaded pH-sensitive nanoparticles in rats. Wang XQ; Dai JD; Zhang H; Zhang X; Wang JC; Zhang Q J Nanosci Nanotechnol; 2008 May; 8(5):2422-31. PubMed ID: 18572658 [TBL] [Abstract][Full Text] [Related]
8. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A. Dai W; Guo Y; Zhang H; Wang X; Zhang Q Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562 [TBL] [Abstract][Full Text] [Related]
9. PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. Italia JL; Bhatt DK; Bhardwaj V; Tikoo K; Kumar MN J Control Release; 2007 Jun; 119(2):197-206. PubMed ID: 17399839 [TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier. Zhang Y; Li X; Zhou Y; Fan Y; Wang X; Huang Y; Liu Y Mol Pharm; 2010 Aug; 7(4):1169-82. PubMed ID: 20540526 [TBL] [Abstract][Full Text] [Related]
11. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers. Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of oral bioavailability of poorly water-soluble drugs by poly(ethylene glycol)-block-poly(alkyl acrylate-co-methacrylic acid) self-assemblies. Sant VP; Smith D; Leroux JC J Control Release; 2005 May; 104(2):289-300. PubMed ID: 15907580 [TBL] [Abstract][Full Text] [Related]
13. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Müller RH; Runge S; Ravelli V; Mehnert W; Thünemann AF; Souto EB Int J Pharm; 2006 Jul; 317(1):82-9. PubMed ID: 16580159 [TBL] [Abstract][Full Text] [Related]
14. Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles. Ubrich N; Schmidt C; Bodmeier R; Hoffman M; Maincent P Int J Pharm; 2005 Jan; 288(1):169-75. PubMed ID: 15607269 [TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers. Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Lai J; Lu Y; Yin Z; Hu F; Wu W Int J Nanomedicine; 2010 Feb; 5():13-23. PubMed ID: 20161984 [TBL] [Abstract][Full Text] [Related]
17. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats. Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208 [TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439 [TBL] [Abstract][Full Text] [Related]
19. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization. Qian F; Cui F; Ding J; Tang C; Yin C Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Wang K; Qi J; Weng T; Tian Z; Lu Y; Hu K; Yin Z; Wu W Int J Nanomedicine; 2014; 9():4991-9. PubMed ID: 25378925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]